Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Analgesics, Opioid | 30 | 2023 | 236 | 8.580 |
Why?
|
Receptors, Opioid | 26 | 2023 | 38 | 8.210 |
Why?
|
Receptors, Opioid, mu | 24 | 2023 | 51 | 5.630 |
Why?
|
Pruritus | 17 | 2020 | 58 | 5.280 |
Why?
|
Opioid Peptides | 14 | 2021 | 28 | 5.040 |
Why?
|
Pain | 20 | 2023 | 282 | 4.460 |
Why?
|
Analgesics | 19 | 2023 | 125 | 3.840 |
Why?
|
Morphine | 16 | 2022 | 57 | 2.970 |
Why?
|
Spinal Cord | 9 | 2016 | 139 | 2.960 |
Why?
|
Animals | 89 | 2023 | 7297 | 2.950 |
Why?
|
Naltrexone | 24 | 2022 | 38 | 2.890 |
Why?
|
Macaca mulatta | 46 | 2021 | 322 | 2.590 |
Why?
|
Narcotic Antagonists | 20 | 2015 | 50 | 2.430 |
Why?
|
Dose-Response Relationship, Drug | 39 | 2022 | 641 | 2.420 |
Why?
|
Receptors, Opioid, kappa | 17 | 2015 | 40 | 2.310 |
Why?
|
Carboxylic Ester Hydrolases | 12 | 2012 | 15 | 2.230 |
Why?
|
Cocaine | 15 | 2016 | 262 | 2.230 |
Why?
|
Behavior, Animal | 12 | 2015 | 264 | 1.910 |
Why?
|
Receptors, Bombesin | 5 | 2020 | 8 | 1.650 |
Why?
|
Hyperalgesia | 9 | 2019 | 88 | 1.610 |
Why?
|
Gastrin-Releasing Peptide | 4 | 2015 | 7 | 1.610 |
Why?
|
Male | 70 | 2022 | 17768 | 1.420 |
Why?
|
Receptors, Opioid, delta | 6 | 2022 | 17 | 1.390 |
Why?
|
Buprenorphine | 5 | 2019 | 18 | 1.310 |
Why?
|
Injections, Spinal | 14 | 2019 | 124 | 1.240 |
Why?
|
Azabicyclo Compounds | 5 | 2019 | 12 | 1.230 |
Why?
|
Piperazines | 6 | 2022 | 56 | 1.220 |
Why?
|
Spiro Compounds | 6 | 2013 | 8 | 1.170 |
Why?
|
RNA, Messenger | 6 | 2019 | 514 | 1.160 |
Why?
|
Capsaicin | 8 | 2009 | 30 | 1.140 |
Why?
|
Benzamides | 4 | 2022 | 54 | 1.090 |
Why?
|
Respiratory Insufficiency | 3 | 2023 | 61 | 1.080 |
Why?
|
Disease Models, Animal | 12 | 2022 | 980 | 1.030 |
Why?
|
Thalamus | 4 | 2018 | 39 | 1.010 |
Why?
|
Bombesin | 6 | 2020 | 8 | 0.990 |
Why?
|
Imidazoles | 4 | 2013 | 104 | 0.970 |
Why?
|
Opioid-Related Disorders | 2 | 2021 | 49 | 0.940 |
Why?
|
Pain Measurement | 17 | 2013 | 360 | 0.940 |
Why?
|
Female | 45 | 2022 | 18114 | 0.920 |
Why?
|
Brain-Derived Neurotrophic Factor | 3 | 2009 | 36 | 0.920 |
Why?
|
Ligands | 7 | 2021 | 81 | 0.910 |
Why?
|
Cannabinoids | 2 | 2022 | 39 | 0.900 |
Why?
|
Amitriptyline | 1 | 2022 | 7 | 0.850 |
Why?
|
Inflammation | 2 | 2016 | 503 | 0.820 |
Why?
|
Cardiovascular System | 2 | 2012 | 38 | 0.810 |
Why?
|
Rats | 19 | 2022 | 1604 | 0.800 |
Why?
|
Urea | 1 | 2020 | 33 | 0.760 |
Why?
|
Primates | 6 | 2022 | 100 | 0.760 |
Why?
|
Thiophenes | 1 | 2020 | 21 | 0.760 |
Why?
|
Mice | 21 | 2021 | 2368 | 0.750 |
Why?
|
Up-Regulation | 4 | 2016 | 183 | 0.730 |
Why?
|
Nerve Tissue Proteins | 2 | 2018 | 118 | 0.730 |
Why?
|
Enkephalin, Ala(2)-MePhe(4)-Gly(5)- | 7 | 2009 | 18 | 0.700 |
Why?
|
Analgesia | 3 | 2021 | 33 | 0.690 |
Why?
|
Diabetes Mellitus, Type 2 | 2 | 2018 | 1374 | 0.670 |
Why?
|
Cocaine-Related Disorders | 6 | 2011 | 106 | 0.660 |
Why?
|
Piperidines | 8 | 2015 | 125 | 0.630 |
Why?
|
Oligopeptides | 4 | 2016 | 51 | 0.630 |
Why?
|
Inflammation Mediators | 1 | 2018 | 101 | 0.620 |
Why?
|
Substance P | 2 | 2015 | 22 | 0.620 |
Why?
|
Seizures | 5 | 2011 | 61 | 0.610 |
Why?
|
Neuropeptides | 2 | 2015 | 18 | 0.600 |
Why?
|
Chemokines | 1 | 2016 | 35 | 0.580 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 2 | 2015 | 71 | 0.580 |
Why?
|
Neurokinin B | 2 | 2019 | 2 | 0.580 |
Why?
|
Neurons | 3 | 2020 | 394 | 0.560 |
Why?
|
Down-Regulation | 1 | 2016 | 142 | 0.560 |
Why?
|
Receptors, Atrial Natriuretic Factor | 1 | 2015 | 2 | 0.560 |
Why?
|
Natriuretic Peptide, Brain | 1 | 2015 | 56 | 0.540 |
Why?
|
Dopamine Uptake Inhibitors | 3 | 2011 | 120 | 0.530 |
Why?
|
Substance-Related Disorders | 2 | 2014 | 109 | 0.530 |
Why?
|
3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer | 9 | 2013 | 13 | 0.520 |
Why?
|
Spinal Nerves | 1 | 2015 | 65 | 0.510 |
Why?
|
Narcotics | 3 | 2008 | 17 | 0.500 |
Why?
|
Antidepressive Agents | 2 | 2022 | 70 | 0.500 |
Why?
|
Rats, Sprague-Dawley | 10 | 2014 | 747 | 0.480 |
Why?
|
Neuralgia | 2 | 2015 | 48 | 0.470 |
Why?
|
Recombinant Proteins | 4 | 2016 | 248 | 0.450 |
Why?
|
Morphine Dependence | 2 | 2008 | 3 | 0.440 |
Why?
|
Sensory Receptor Cells | 3 | 2021 | 29 | 0.410 |
Why?
|
Peptide Fragments | 6 | 2020 | 420 | 0.400 |
Why?
|
Neurotransmitter Agents | 1 | 2011 | 26 | 0.400 |
Why?
|
Hot Temperature | 8 | 2009 | 71 | 0.390 |
Why?
|
Benzimidazoles | 6 | 2014 | 33 | 0.390 |
Why?
|
Pyridines | 4 | 2019 | 78 | 0.380 |
Why?
|
Adrenocorticotropic Hormone | 2 | 2008 | 22 | 0.380 |
Why?
|
Dynorphins | 3 | 2015 | 9 | 0.370 |
Why?
|
Indoles | 4 | 2019 | 58 | 0.370 |
Why?
|
Humans | 17 | 2023 | 29013 | 0.360 |
Why?
|
Conditioning, Operant | 4 | 2011 | 96 | 0.330 |
Why?
|
Hydrocortisone | 2 | 2008 | 61 | 0.330 |
Why?
|
Mutation | 1 | 2011 | 466 | 0.330 |
Why?
|
Butorphanol | 2 | 2007 | 4 | 0.320 |
Why?
|
Cisterna Magna | 2 | 2015 | 3 | 0.320 |
Why?
|
Fentanyl | 5 | 2013 | 33 | 0.310 |
Why?
|
Substance Withdrawal Syndrome | 2 | 2008 | 53 | 0.300 |
Why?
|
Analgesics, Non-Narcotic | 5 | 2003 | 16 | 0.300 |
Why?
|
Diuresis | 3 | 2003 | 9 | 0.300 |
Why?
|
Macrophages | 2 | 2021 | 188 | 0.300 |
Why?
|
Injections, Intraventricular | 5 | 2009 | 16 | 0.290 |
Why?
|
Drug Tolerance | 2 | 2019 | 36 | 0.290 |
Why?
|
Macaca fascicularis | 2 | 2018 | 389 | 0.280 |
Why?
|
Drug Design | 3 | 2018 | 44 | 0.270 |
Why?
|
Motor Activity | 3 | 2013 | 310 | 0.270 |
Why?
|
Self Administration | 7 | 2014 | 296 | 0.270 |
Why?
|
Respiration | 2 | 2002 | 26 | 0.260 |
Why?
|
Pain Threshold | 2 | 2019 | 94 | 0.260 |
Why?
|
Grooming | 1 | 2003 | 2 | 0.240 |
Why?
|
Stereotyped Behavior | 1 | 2003 | 14 | 0.240 |
Why?
|
Brain | 4 | 2022 | 930 | 0.240 |
Why?
|
Heroin | 2 | 2022 | 14 | 0.230 |
Why?
|
Benzomorphans | 4 | 2008 | 5 | 0.230 |
Why?
|
Macaca | 2 | 2013 | 25 | 0.230 |
Why?
|
GTP-Binding Proteins | 1 | 2003 | 24 | 0.230 |
Why?
|
Mice, Inbred ICR | 4 | 2020 | 14 | 0.220 |
Why?
|
Cerebral Cortex | 2 | 2003 | 141 | 0.220 |
Why?
|
Time Factors | 7 | 2013 | 1997 | 0.220 |
Why?
|
Rats, Wistar | 4 | 2011 | 84 | 0.220 |
Why?
|
Neurodegenerative Diseases | 1 | 2022 | 13 | 0.210 |
Why?
|
Body Temperature | 2 | 2012 | 22 | 0.210 |
Why?
|
Interleukin-23 | 1 | 2021 | 14 | 0.200 |
Why?
|
Interleukin-17 | 1 | 2021 | 14 | 0.200 |
Why?
|
TRPV Cation Channels | 1 | 2021 | 19 | 0.200 |
Why?
|
Estrogen Receptor alpha | 1 | 2021 | 50 | 0.200 |
Why?
|
Nociceptors | 1 | 2021 | 41 | 0.200 |
Why?
|
Interferon Type I | 1 | 2021 | 14 | 0.200 |
Why?
|
Guanosine 5'-O-(3-Thiotriphosphate) | 5 | 2013 | 24 | 0.200 |
Why?
|
Gene Expression Regulation | 2 | 2018 | 481 | 0.200 |
Why?
|
Polyethylene Glycols | 2 | 2011 | 65 | 0.190 |
Why?
|
Morphinans | 3 | 2008 | 4 | 0.190 |
Why?
|
Structure-Activity Relationship | 2 | 2018 | 82 | 0.190 |
Why?
|
Integrins | 1 | 2020 | 20 | 0.190 |
Why?
|
Receptors, AMPA | 1 | 2020 | 14 | 0.190 |
Why?
|
Cell Adhesion Molecules | 1 | 2020 | 45 | 0.180 |
Why?
|
Drug Synergism | 3 | 2009 | 67 | 0.180 |
Why?
|
Peripheral Nervous System | 1 | 1999 | 6 | 0.180 |
Why?
|
Sulfur Radioisotopes | 4 | 2011 | 9 | 0.180 |
Why?
|
Central Nervous System | 1 | 1999 | 29 | 0.180 |
Why?
|
Butyrylcholinesterase | 2 | 2010 | 15 | 0.180 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 2 | 2011 | 152 | 0.180 |
Why?
|
Cell Degranulation | 1 | 2019 | 4 | 0.180 |
Why?
|
Heart Rate | 2 | 2012 | 315 | 0.180 |
Why?
|
Drug Interactions | 4 | 2011 | 80 | 0.180 |
Why?
|
Mast Cells | 1 | 2019 | 17 | 0.180 |
Why?
|
Membrane Proteins | 1 | 2021 | 256 | 0.170 |
Why?
|
Drug Evaluation, Preclinical | 1 | 2019 | 58 | 0.170 |
Why?
|
Oxycodone | 1 | 2018 | 7 | 0.170 |
Why?
|
Radioligand Assay | 5 | 2005 | 23 | 0.170 |
Why?
|
Nerve Growth Factors | 1 | 2018 | 18 | 0.170 |
Why?
|
Toll-Like Receptors | 1 | 2018 | 22 | 0.160 |
Why?
|
Alzheimer Disease | 1 | 2022 | 312 | 0.160 |
Why?
|
Gene Expression | 2 | 2019 | 332 | 0.160 |
Why?
|
Antibodies | 2 | 2009 | 53 | 0.160 |
Why?
|
Analysis of Variance | 2 | 2011 | 454 | 0.150 |
Why?
|
Calcium | 3 | 2019 | 296 | 0.150 |
Why?
|
Injections, Subcutaneous | 3 | 2003 | 33 | 0.150 |
Why?
|
Injections, Intravenous | 2 | 2011 | 73 | 0.150 |
Why?
|
Blood Pressure | 2 | 2012 | 803 | 0.150 |
Why?
|
Swimming | 2 | 2007 | 7 | 0.150 |
Why?
|
Cytokines | 1 | 2018 | 243 | 0.150 |
Why?
|
Pyrrolidines | 3 | 2008 | 13 | 0.150 |
Why?
|
Microglia | 1 | 2016 | 48 | 0.140 |
Why?
|
Alfentanil | 2 | 2009 | 3 | 0.140 |
Why?
|
Alcohol Drinking | 1 | 2019 | 243 | 0.140 |
Why?
|
Reaction Time | 3 | 2008 | 121 | 0.140 |
Why?
|
Carrageenan | 2 | 2013 | 5 | 0.140 |
Why?
|
Tetrahydroisoquinolines | 1 | 2015 | 3 | 0.140 |
Why?
|
Atrial Natriuretic Factor | 1 | 2015 | 10 | 0.140 |
Why?
|
Pituitary-Adrenal System | 2 | 2008 | 24 | 0.140 |
Why?
|
Hypothalamo-Hypophyseal System | 2 | 2008 | 34 | 0.140 |
Why?
|
beta-Endorphin | 1 | 2015 | 2 | 0.140 |
Why?
|
Blood Glucose | 1 | 2018 | 465 | 0.130 |
Why?
|
Cycloheptanes | 1 | 2015 | 1 | 0.130 |
Why?
|
Chemokine CCL3 | 1 | 2015 | 6 | 0.130 |
Why?
|
Hydrolysis | 2 | 2012 | 38 | 0.130 |
Why?
|
Lumbosacral Region | 1 | 2015 | 12 | 0.130 |
Why?
|
Azocines | 3 | 2000 | 3 | 0.130 |
Why?
|
STAT3 Transcription Factor | 1 | 2015 | 22 | 0.130 |
Why?
|
Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 2 | 2006 | 27 | 0.130 |
Why?
|
Interleukin-1beta | 1 | 2015 | 41 | 0.130 |
Why?
|
Haloperidol | 1 | 1995 | 5 | 0.130 |
Why?
|
Catheterization | 1 | 2015 | 58 | 0.130 |
Why?
|
Benzazepines | 1 | 1995 | 22 | 0.130 |
Why?
|
Nicotinic Agonists | 1 | 2015 | 48 | 0.130 |
Why?
|
Ileum | 2 | 2013 | 13 | 0.130 |
Why?
|
Bacterial Proteins | 2 | 2011 | 77 | 0.120 |
Why?
|
Mutagenesis, Site-Directed | 2 | 2010 | 60 | 0.120 |
Why?
|
Phenalenes | 1 | 2013 | 1 | 0.120 |
Why?
|
Rhodococcus | 2 | 2010 | 2 | 0.120 |
Why?
|
Naloxone | 2 | 2013 | 23 | 0.120 |
Why?
|
Binding, Competitive | 3 | 2008 | 38 | 0.110 |
Why?
|
Anesthesia, Spinal | 1 | 2013 | 21 | 0.110 |
Why?
|
Cells, Cultured | 3 | 2021 | 799 | 0.110 |
Why?
|
Antipruritics | 2 | 2003 | 6 | 0.110 |
Why?
|
Antibody Formation | 1 | 2012 | 39 | 0.110 |
Why?
|
Area Under Curve | 2 | 2011 | 84 | 0.110 |
Why?
|
Signal Transduction | 3 | 2021 | 666 | 0.100 |
Why?
|
Bacteria | 1 | 2011 | 45 | 0.100 |
Why?
|
Pyrroles | 2 | 2008 | 55 | 0.100 |
Why?
|
Diazepam | 1 | 2010 | 6 | 0.100 |
Why?
|
Autoradiography | 2 | 2011 | 47 | 0.100 |
Why?
|
Mass Spectrometry | 2 | 2011 | 99 | 0.090 |
Why?
|
Molecular Dynamics Simulation | 1 | 2010 | 15 | 0.090 |
Why?
|
Central Nervous System Agents | 1 | 2009 | 3 | 0.090 |
Why?
|
Substance Abuse, Intravenous | 1 | 2009 | 27 | 0.090 |
Why?
|
Antibody Specificity | 1 | 2009 | 14 | 0.090 |
Why?
|
Posture | 1 | 2009 | 53 | 0.080 |
Why?
|
Hydrolases | 1 | 2008 | 6 | 0.080 |
Why?
|
Restraint, Physical | 1 | 2008 | 10 | 0.080 |
Why?
|
Anticonvulsants | 1 | 2009 | 63 | 0.080 |
Why?
|
Drug Partial Agonism | 1 | 2008 | 3 | 0.080 |
Why?
|
Enkephalins | 2 | 1998 | 7 | 0.080 |
Why?
|
Cricetulus | 3 | 2016 | 17 | 0.080 |
Why?
|
Cricetinae | 3 | 2016 | 58 | 0.080 |
Why?
|
Mice, Inbred C57BL | 2 | 2021 | 711 | 0.080 |
Why?
|
Gas Gangrene | 1 | 2007 | 1 | 0.080 |
Why?
|
Monkey Diseases | 1 | 2007 | 18 | 0.080 |
Why?
|
Tritium | 2 | 2004 | 17 | 0.070 |
Why?
|
Enzyme Stability | 3 | 2011 | 8 | 0.070 |
Why?
|
Electrocardiography | 1 | 2011 | 562 | 0.070 |
Why?
|
Freezing Reaction, Cataleptic | 1 | 2006 | 1 | 0.070 |
Why?
|
In Situ Hybridization | 1 | 2006 | 35 | 0.070 |
Why?
|
Kinetics | 3 | 2011 | 205 | 0.070 |
Why?
|
Binding Sites | 1 | 2005 | 125 | 0.070 |
Why?
|
Neurosecretory Systems | 1 | 2005 | 4 | 0.070 |
Why?
|
Immune System | 1 | 2005 | 8 | 0.070 |
Why?
|
Receptors, Neurotensin | 1 | 2004 | 2 | 0.070 |
Why?
|
Neurotensin | 1 | 2004 | 4 | 0.070 |
Why?
|
Nervous System | 1 | 2005 | 15 | 0.070 |
Why?
|
Hypothermia | 1 | 2004 | 12 | 0.060 |
Why?
|
Hypotension | 1 | 2004 | 47 | 0.060 |
Why?
|
Histamine | 1 | 2004 | 3 | 0.060 |
Why?
|
Atmospheric Pressure | 1 | 2004 | 12 | 0.060 |
Why?
|
Spectrometry, Mass, Electrospray Ionization | 1 | 2004 | 34 | 0.060 |
Why?
|
Premedication | 1 | 2003 | 10 | 0.060 |
Why?
|
Enkephalin, D-Penicillamine (2,5)- | 1 | 2003 | 5 | 0.060 |
Why?
|
Dermatology | 1 | 2005 | 154 | 0.060 |
Why?
|
Morphine Derivatives | 2 | 2003 | 3 | 0.060 |
Why?
|
Cinnamates | 2 | 2003 | 3 | 0.060 |
Why?
|
Cell Membrane | 1 | 2003 | 97 | 0.060 |
Why?
|
Heating | 1 | 2002 | 2 | 0.050 |
Why?
|
Tail | 1 | 2002 | 6 | 0.050 |
Why?
|
CHO Cells | 2 | 2016 | 25 | 0.050 |
Why?
|
Benzeneacetamides | 1 | 2001 | 3 | 0.050 |
Why?
|
tau Proteins | 1 | 2022 | 38 | 0.050 |
Why?
|
Nerve Fibers, Unmyelinated | 1 | 2021 | 6 | 0.050 |
Why?
|
Crystallography, X-Ray | 2 | 2011 | 77 | 0.050 |
Why?
|
Diltiazem | 1 | 2000 | 1 | 0.050 |
Why?
|
Injections, Intramuscular | 1 | 2000 | 42 | 0.050 |
Why?
|
Integrin alpha5 | 1 | 2020 | 1 | 0.050 |
Why?
|
Integrin beta3 | 1 | 2020 | 10 | 0.050 |
Why?
|
Calcium Channel Blockers | 1 | 2000 | 49 | 0.050 |
Why?
|
Keratinocytes | 1 | 2020 | 26 | 0.050 |
Why?
|
Pilot Projects | 1 | 2022 | 469 | 0.050 |
Why?
|
Excitatory Amino Acid Antagonists | 1 | 2020 | 26 | 0.050 |
Why?
|
Anesthesia, Local | 1 | 2000 | 16 | 0.050 |
Why?
|
Cyclopropanes | 1 | 2020 | 19 | 0.050 |
Why?
|
Hypersensitivity | 1 | 2020 | 25 | 0.050 |
Why?
|
Dogs | 1 | 2020 | 117 | 0.050 |
Why?
|
Temperature | 2 | 2010 | 55 | 0.050 |
Why?
|
Injections | 1 | 1999 | 61 | 0.040 |
Why?
|
Species Specificity | 2 | 2011 | 84 | 0.040 |
Why?
|
Guinea Pigs | 2 | 2013 | 12 | 0.040 |
Why?
|
Toluene 2,4-Diisocyanate | 1 | 2019 | 1 | 0.040 |
Why?
|
Injections, Intradermal | 1 | 2019 | 7 | 0.040 |
Why?
|
Receptors, Drug | 1 | 1999 | 14 | 0.040 |
Why?
|
Sex Factors | 1 | 2021 | 626 | 0.040 |
Why?
|
Dermatitis, Allergic Contact | 1 | 2019 | 11 | 0.040 |
Why?
|
Models, Molecular | 2 | 2010 | 178 | 0.040 |
Why?
|
Receptors, Cannabinoid | 1 | 1999 | 26 | 0.040 |
Why?
|
Peptides | 1 | 1999 | 118 | 0.040 |
Why?
|
Pyrazoles | 1 | 1999 | 64 | 0.040 |
Why?
|
Ganglia, Spinal | 1 | 2019 | 63 | 0.040 |
Why?
|
Eating | 1 | 2019 | 73 | 0.040 |
Why?
|
Dermatitis, Atopic | 1 | 2020 | 86 | 0.040 |
Why?
|
Brain Chemistry | 1 | 1998 | 30 | 0.040 |
Why?
|
Skin | 1 | 2020 | 203 | 0.040 |
Why?
|
Data Interpretation, Statistical | 1 | 2008 | 103 | 0.040 |
Why?
|
Tyrphostins | 1 | 2015 | 2 | 0.030 |
Why?
|
Aging | 1 | 2022 | 880 | 0.030 |
Why?
|
Lipopolysaccharides | 1 | 2015 | 107 | 0.030 |
Why?
|
Calcium Channels, N-Type | 1 | 2014 | 4 | 0.030 |
Why?
|
Phosphorylation | 1 | 2015 | 225 | 0.030 |
Why?
|
Protein Isoforms | 1 | 2014 | 56 | 0.030 |
Why?
|
Receptors, Nicotinic | 1 | 2015 | 60 | 0.030 |
Why?
|
Anti-Inflammatory Agents | 1 | 2015 | 90 | 0.030 |
Why?
|
Electric Stimulation | 1 | 2013 | 102 | 0.030 |
Why?
|
Protein Binding | 1 | 2013 | 199 | 0.030 |
Why?
|
Sweetening Agents | 1 | 2011 | 8 | 0.030 |
Why?
|
Spectrometry, Fluorescence | 1 | 2011 | 24 | 0.030 |
Why?
|
Sucrose | 1 | 2011 | 17 | 0.030 |
Why?
|
Isotope Labeling | 1 | 2011 | 17 | 0.030 |
Why?
|
Calibration | 1 | 2011 | 25 | 0.030 |
Why?
|
Injections, Intraperitoneal | 1 | 2011 | 41 | 0.030 |
Why?
|
Immunoenzyme Techniques | 1 | 2011 | 46 | 0.030 |
Why?
|
Protein Stability | 1 | 2011 | 26 | 0.030 |
Why?
|
Ketamine | 1 | 2011 | 20 | 0.030 |
Why?
|
Protein Subunits | 1 | 2011 | 34 | 0.030 |
Why?
|
Food Preferences | 1 | 2011 | 35 | 0.030 |
Why?
|
Reinforcement Schedule | 1 | 2011 | 60 | 0.030 |
Why?
|
Methylphenidate | 1 | 2011 | 36 | 0.030 |
Why?
|
Hydrogen Bonding | 1 | 2010 | 18 | 0.020 |
Why?
|
Blotting, Western | 1 | 2011 | 281 | 0.020 |
Why?
|
Acetylcholine | 1 | 2010 | 47 | 0.020 |
Why?
|
Glomerular Filtration Rate | 1 | 2011 | 286 | 0.020 |
Why?
|
Nephrectomy | 1 | 2011 | 114 | 0.020 |
Why?
|
Protein Conformation | 1 | 2010 | 85 | 0.020 |
Why?
|
Trypsin | 1 | 2009 | 12 | 0.020 |
Why?
|
Escherichia coli | 1 | 2010 | 82 | 0.020 |
Why?
|
Nalbuphine | 2 | 2000 | 2 | 0.020 |
Why?
|
Quantum Theory | 1 | 2008 | 2 | 0.020 |
Why?
|
Stereoisomerism | 1 | 2008 | 21 | 0.020 |
Why?
|
Substrate Specificity | 1 | 2008 | 84 | 0.020 |
Why?
|
Thermodynamics | 1 | 2008 | 45 | 0.020 |
Why?
|
Middle Aged | 1 | 2022 | 10805 | 0.020 |
Why?
|
Clostridium perfringens | 1 | 2007 | 2 | 0.020 |
Why?
|
Kallidin | 1 | 2007 | 1 | 0.020 |
Why?
|
Receptor, Bradykinin B1 | 1 | 2007 | 2 | 0.020 |
Why?
|
Microsomes, Liver | 1 | 2007 | 11 | 0.020 |
Why?
|
Computer Simulation | 1 | 2008 | 202 | 0.020 |
Why?
|
Naproxen | 1 | 2007 | 8 | 0.020 |
Why?
|
Cell Membrane Permeability | 1 | 2007 | 14 | 0.020 |
Why?
|
Bradykinin | 1 | 2007 | 18 | 0.020 |
Why?
|
Molecular Structure | 1 | 2007 | 53 | 0.020 |
Why?
|
Debridement | 1 | 2007 | 43 | 0.020 |
Why?
|
Transfection | 1 | 2007 | 192 | 0.020 |
Why?
|
Fibroblasts | 1 | 2007 | 103 | 0.020 |
Why?
|
Cell Line | 1 | 2007 | 449 | 0.020 |
Why?
|
Mice, Knockout | 1 | 2007 | 425 | 0.020 |
Why?
|
Vas Deferens | 1 | 2004 | 1 | 0.020 |
Why?
|
Muscle Contraction | 1 | 2004 | 114 | 0.020 |
Why?
|
Sensitivity and Specificity | 1 | 2004 | 531 | 0.010 |
Why?
|
Cell Line, Tumor | 1 | 2004 | 680 | 0.010 |
Why?
|
Ethylketocyclazocine | 1 | 2001 | 1 | 0.010 |
Why?
|
Membranes | 1 | 2001 | 11 | 0.010 |
Why?
|
Muscle Relaxation | 1 | 2001 | 7 | 0.010 |
Why?
|
Prolactin | 1 | 2001 | 10 | 0.010 |
Why?
|
Respiratory Mechanics | 1 | 2001 | 8 | 0.010 |
Why?
|
Clonidine | 1 | 2000 | 60 | 0.010 |
Why?
|
Sequence Analysis | 1 | 1999 | 6 | 0.010 |
Why?
|
Pyrrolidonecarboxylic Acid | 1 | 1999 | 5 | 0.010 |
Why?
|
Benzofurans | 1 | 1998 | 5 | 0.010 |
Why?
|